Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study to Examine the Safety and Efficacy of a Novel Liposomal Based Intranasal Influenza Vaccine

NCT00197301 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00197301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00197301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study to Examine the Safety and Efficacy of a Novel Liposomal Based Intranasal Influenza Vaccine
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2005
Completion date
April 30, 2006
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza